<DOC>
	<DOCNO>NCT02648659</DOCNO>
	<brief_summary>This study assess effect tailor eradication therapy accord Clarithromycin resistance Helicobacter pylorus patient .</brief_summary>
	<brief_title>The Pilot Study Tailored Eradication Therapy According Clarithromycin Resistance H.Pylori Patients</brief_title>
	<detailed_description>This study assess effect tailor eradication therapy accord Clarithromycin resistance Helicobacter pylorus patient . The patient gastric duodenal ulcer endoscopy register study inspect Rapid Urease test , Biopsy , IgG-Hp antibody . The tailored eradication therapy prescribe patient confirm Helicobacter pylorus positive two among three test 14 day . Through , This study ass effectiveness eradication rate evaluate safety tolerability Ilaprazole 10mg qid treatment</detailed_description>
	<mesh_term>Peptic Ulcer</mesh_term>
	<mesh_term>Metronidazole</mesh_term>
	<mesh_term>Clarithromycin</mesh_term>
	<mesh_term>Amoxicillin</mesh_term>
	<criteria>• 20 year old ≤ Male female &lt; 80 year old Among Patients gastric duodenal ulcer endoscopy , Subject identify Helicobacter pyloripositive conduct two follow test ; Rapid Urease test , Biopsy test , IgGHp antibody test . Subject fully understand condition clinical trial Subject agree participate spontaneously sign ICF Known hypersensitivity experimental concomitant drug Subjects take contraindicated medication experimental concomitant drug . Subjects abnormal level laboratory test Total Bilirubin , Creatinine &gt; 1.5 time upper limit normal AST , ALT , Alkaline phosphatase , BUN &gt; 2 time upper limit normal Administrated PPI , antibiotic medication within 2 week prior commencement study . Pregnant and/or lactate woman Reproductive age woman use contraception Uncontrolled diabetic Uncontrolled hypertension Uncontrolled liver dysfunction Alcoholics Subjects history possibility digestive malignancy within 5 year Subjects history gastrectomy esophagectomy Subjects hereditary disease Galactose intolerance , Lapp lactose deficiency , glucosegalactose malabsorption Subjects participate clinical trial another trial within 30 day Inconsistence judge subject researcher</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>